Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1992 Feb;47(2):119–126. doi: 10.1136/thx.47.2.119

New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.

N Thatcher 1
PMCID: PMC463590  PMID: 1372450

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson H., Gurney H., Thatcher N., Swindell R., Scarffe J. H., Weiner J. Recombinant human GM-CSF in small cell lung cancer: a phase I/II study. Recent Results Cancer Res. 1991;121:155–161. doi: 10.1007/978-3-642-84138-5_17. [DOI] [PubMed] [Google Scholar]
  2. Antman K. S., Griffin J. D., Elias A., Socinski M. A., Ryan L., Cannistra S. A., Oette D., Whitley M., Frei E., 3rd, Schnipper L. E. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med. 1988 Sep 8;319(10):593–598. doi: 10.1056/NEJM198809083191001. [DOI] [PubMed] [Google Scholar]
  3. Appelbaum F. R. The clinical use of hematopoietic growth factors. Semin Hematol. 1989 Jul;26(3 Suppl 3):7–14. [PubMed] [Google Scholar]
  4. Ardizzoni A., Sertoli M. R., Corcione A., Pennucci M. C., Baldini E., Intra E., Ferrarini M., Rosso R., Mazzanti P., Pistoia V. Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study. Eur J Cancer. 1990;26(9):937–941. doi: 10.1016/0277-5379(90)90614-y. [DOI] [PubMed] [Google Scholar]
  5. Avalos B. R., Gasson J. C., Hedvat C., Quan S. G., Baldwin G. C., Weisbart R. H., Williams R. E., Golde D. W., DiPersio J. F. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood. 1990 Feb 15;75(4):851–857. [PubMed] [Google Scholar]
  6. Brandt S. J., Peters W. P., Atwater S. K., Kurtzberg J., Borowitz M. J., Jones R. B., Shpall E. J., Bast R. C., Jr, Gilbert C. J., Oette D. H. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med. 1988 Apr 7;318(14):869–876. doi: 10.1056/NEJM198804073181401. [DOI] [PubMed] [Google Scholar]
  7. Bronchud M. H., Howell A., Crowther D., Hopwood P., Souza L., Dexter T. M. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer. 1989 Jul;60(1):121–125. doi: 10.1038/bjc.1989.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bronchud M. H., Potter M. R., Morgenstern G., Blasco M. J., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G. In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer. 1988 Jul;58(1):64–69. doi: 10.1038/bjc.1988.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bronchud M. H., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer. 1987 Dec;56(6):809–813. doi: 10.1038/bjc.1987.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cox R., Musial T., Gyde O. H. Reduced erythropoietin levels as a cause of anaemia in patients with lung cancer. Eur J Cancer Clin Oncol. 1986 Apr;22(4):511–514. doi: 10.1016/0277-5379(86)90120-3. [DOI] [PubMed] [Google Scholar]
  11. Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991 Jul 18;325(3):164–170. doi: 10.1056/NEJM199107183250305. [DOI] [PubMed] [Google Scholar]
  12. Dodwell D. J., Gurney H., Thatcher N. Dose intensity in cancer chemotherapy. Br J Cancer. 1990 Jun;61(6):789–794. doi: 10.1038/bjc.1990.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drings P., Fischer J. R. Biology and clinical use of GM-CSF in lung cancer. Lung. 1990;168 (Suppl):1059–1068. doi: 10.1007/BF02718244. [DOI] [PubMed] [Google Scholar]
  14. Eguchi K., Sasaki S., Tamura T., Sasaki Y., Shinkai T., Yamada K., Soejima Y., Fukuda M., Fujihara Y., Kunitou H. Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy. Cancer Res. 1989 Sep 15;49(18):5221–5224. [PubMed] [Google Scholar]
  15. Gabrilove J. L., Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore M. A., Clarkson B. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med. 1988 Jun 2;318(22):1414–1422. doi: 10.1056/NEJM198806023182202. [DOI] [PubMed] [Google Scholar]
  16. Gianni A. M., Bregni M., Siena S., Villa S., Sciorelli G. A., Ravagnani F., Pellegris G., Bonadonna G. Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy? Hematol Oncol. 1989 Mar-Apr;7(2):139–148. doi: 10.1002/hon.2900070205. [DOI] [PubMed] [Google Scholar]
  17. Gianni A. M., Siena S., Bregni M., Tarella C., Stern A. C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet. 1989 Sep 9;2(8663):580–585. doi: 10.1016/s0140-6736(89)90711-3. [DOI] [PubMed] [Google Scholar]
  18. Glover D., Glick J. H., Weiler C., Fox K., Guerry D. WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma. J Clin Oncol. 1987 Apr;5(4):574–578. doi: 10.1200/JCO.1987.5.4.574. [DOI] [PubMed] [Google Scholar]
  19. Glover D., Glick J. H., Weiler C., Hurowitz S., Kligerman M. M. WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial. J Clin Oncol. 1986 Apr;4(4):584–588. doi: 10.1200/JCO.1986.4.4.584. [DOI] [PubMed] [Google Scholar]
  20. Griffin J. D. Hemopoietins in oncology: factoring out myelosuppression. J Clin Oncol. 1989 Feb;7(2):151–155. doi: 10.1200/JCO.1989.7.2.151. [DOI] [PubMed] [Google Scholar]
  21. Groopman J. E. Status of colony-stimulating factors in cancer and AIDS. Semin Oncol. 1990 Feb;17(1 Suppl 1):31–41. [PubMed] [Google Scholar]
  22. Henon P. R., Butturini A., Gale R. P. Blood-derived haematopoietic cell transplants: blood to blood? Lancet. 1991 Apr 20;337(8747):961–963. doi: 10.1016/0140-6736(91)91583-g. [DOI] [PubMed] [Google Scholar]
  23. Lieschke G. J., Maher D., Cebon J., O'Connor M., Green M., Sheridan W., Boyd A., Rallings M., Bonnem E., Metcalf D. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Ann Intern Med. 1989 Mar 1;110(5):357–364. doi: 10.7326/0003-4819-110-5-357. [DOI] [PubMed] [Google Scholar]
  24. Metcalf D. Haemopoietic growth factors 1. Lancet. 1989 Apr 15;1(8642):825–827. doi: 10.1016/s0140-6736(89)92280-0. [DOI] [PubMed] [Google Scholar]
  25. Metcalf D. Haemopoietic growth factors 2: clinical applications. Lancet. 1989 Apr 22;1(8643):885–887. doi: 10.1016/s0140-6736(89)92874-2. [DOI] [PubMed] [Google Scholar]
  26. Miller C. B., Jones R. J., Piantadosi S., Abeloff M. D., Spivak J. L. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med. 1990 Jun 14;322(24):1689–1692. doi: 10.1056/NEJM199006143222401. [DOI] [PubMed] [Google Scholar]
  27. Miyagawa K., Chiba S., Shibuya K., Piao Y. F., Matsuki S., Yokota J., Terada M., Miyazono K., Takaku F. Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines. J Cell Physiol. 1990 Jun;143(3):483–487. doi: 10.1002/jcp.1041430312. [DOI] [PubMed] [Google Scholar]
  28. Morstyn G., Campbell L., Lieschke G., Layton J. E., Maher D., O'Connor M., Green M., Sheridan W., Vincent M., Alton K. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol. 1989 Oct;7(10):1554–1562. doi: 10.1200/JCO.1989.7.10.1554. [DOI] [PubMed] [Google Scholar]
  29. Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988 Mar 26;1(8587):667–672. doi: 10.1016/s0140-6736(88)91475-4. [DOI] [PubMed] [Google Scholar]
  30. Neidhart J., Mangalik A., Kohler W., Stidley C., Saiki J., Duncan P., Souza L., Downing M. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J Clin Oncol. 1989 Nov;7(11):1685–1692. doi: 10.1200/JCO.1989.7.11.1685. [DOI] [PubMed] [Google Scholar]
  31. Prendiville J., Radford J., Thatcher N., Steward W., Ranson M., Burt P., Stout R. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. J Clin Oncol. 1991 Aug;9(8):1446–1452. doi: 10.1200/JCO.1991.9.8.1446. [DOI] [PubMed] [Google Scholar]
  32. Ravagnani F., Siena S., Bregni M., Sciorelli G., Gianni A. M., Pellegris G. Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF. Eur J Cancer. 1990;26(5):562–564. doi: 10.1016/0277-5379(90)90076-6. [DOI] [PubMed] [Google Scholar]
  33. Sheridan W. P., Morstyn G., Wolf M., Dodds A., Lusk J., Maher D., Layton J. E., Green M. D., Souza L., Fox R. M. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 1989 Oct 14;2(8668):891–895. doi: 10.1016/s0140-6736(89)91552-3. [DOI] [PubMed] [Google Scholar]
  34. Steward W. P., Scarffe J. H., Austin R., Bonnem E., Thatcher N., Morgenstern G., Crowther D. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study. Br J Cancer. 1989 Jan;59(1):142–145. doi: 10.1038/bjc.1989.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Steward W. P., Thatcher N., Kaye S. B. Clinical applications of myeloid colony stimulating factors. Cancer Treat Rev. 1990 Mar;17(1):77–87. doi: 10.1016/0305-7372(90)90077-s. [DOI] [PubMed] [Google Scholar]
  36. Thatcher N., Lind M., Stout R., Payne C., Carroll K. B., Campbell C., Moussalli H. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus. Br J Cancer. 1989 Jul;60(1):98–101. doi: 10.1038/bjc.1989.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vellenga E., Biesma B., Meyer C., Wagteveld L., Esselink M., de Vries E. G. The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: interleukin 3 enhances the proliferation in one of the eleven cell lines. Cancer Res. 1991 Jan 1;51(1):73–76. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES